Investors Want To Block $890M Go-Private Sale Of Radius
Investors have hit biopharmaceutical company Radius Health with a lawsuit seeking to block its $890 million go-private sale to Gurnet Point Capital LLC and Patient Square Capital, arguing stockholders need more...To view the full article, register now.
Already a subscriber? Click here to view full article